ClinicalTrials.Veeva

Menu

Prospective Registry of Patients With Isolated Severe Tricuspid Regurgitation

A

Asan Medical Center

Status

Completed

Conditions

Tricuspid Regurgitation

Study type

Observational

Funder types

Other

Identifiers

NCT01502462
Severe_Isol_TR

Details and patient eligibility

About

Prospective registry for patients with severe isolated tricuspid regurgitation (TR) without significant left-sided valvular or myocardial diseases.

Aim: To evaluate clinical course and prognostic factors of patients with severe isolated TR.

Full description

Inclusion criteria Severe isolated TR for more than 6 months

Exclusion criteria

  1. Severe mitral and aortic valvular heart disease
  2. Age equals to or more than 75 years
  3. Malignancy or serious comorbidity with life expectancy < 5years
  4. Acute or subacute infective endocarditis requiring antibiotics therapy
  5. Untreated hyperthyroidism
  6. Constrictive pericarditis
  7. Unclosed significant atrial septal defect
  8. Previous tricuspid valve surgery
  9. Significant coronary artery disease
  10. Cardiomyopathy
  11. Pregnancy
  12. Severe resting pulmonary hypertension(TR Vmax >4.0 m/s)

Enrollment

131 patients

Sex

All

Ages

16 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

  • Severe isolated TR for more than 6 months

Exclusion criteria

  1. Severe mitral and aortic valvular heart disease
  2. Age equals to or more than 75 years
  3. Malignancy or serious comorbidity with life expectancy < 5years
  4. Acute or subacute infective endocarditis requiring antibiotics therapy
  5. Untreated hyperthyroidism
  6. Constrictive pericarditis
  7. Unclosed significant atrial septal defect
  8. Previous tricuspid valve surgery
  9. Significant coronary artery disease
  10. Cardiomyopathy
  11. Pregnancy
  12. Severe resting pulmonary hypertension(TR Vmax >4.0 m/s)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems